SCHEMBL15027014

SCHEMBL15027014

CCCC1(CC)CCN(C)C1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.31
OPRM1 P35372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23466106 1.00 DRD4 (0.31) DRD4OPRM1
SCHEMBL15026989 0.91 DRD4 (0.32) DRD4OPRM1
SCHEMBL14208013 0.89 OPRM1 (0.31) OPRM1
SCHEMBL24337210 0.88 S1PR1 (0.33) OPRM1
SCHEMBL22663662 0.88 SLC22A1 (0.32) OPRM1
SCHEMBL8179035 0.86 CHRM2 (0.32)
SCHEMBL9060316 0.86 OPRM1 (0.34) DRD4OPRM1
SCHEMBL25931160 0.83 DRD4 (0.32) DRD4OPRM1
SCHEMBL14885151 0.81 CHRM2 (0.34)
SCHEMBL20939106 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4223754-A1 COMPOUND AS AKT KINASE INHIBITOR CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-08-09 EP disclosed
EP-3656782-A1 PEPTIDE AMIDE COMPOUND AND PREPARATION METHOD AND MEDICAL USE THEREOF Sichuan Haisco Pharmaceutical Co., Ltd. (CN) 2020-05-27 EP disclosed
WO-2020099886-A1 LOX INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2020-05-22 WO disclosed